Drug Name (Fingolimod SPC (fingolimod Drug Class Immunosuppressant Risk minimization type Healthcare provider checklist Specialty (Theraputic area) Neurology Risk Safety information about: contraindication in pregnant women and in women of childbearing potential not using effective contraception Communication on progressive multifocal leukoencephalopathy (PML) Hemophagocytic syndrome (HPS) Cardiovascular Adverse Events after the First Dose Slow heart rate and irregular heartbeat. Instructions for proper use DHPC: Updated recommendations to minimize the risk of drug-induced liver injury Dear Healthcare provider letter DHPC Healthcare provider checklist